UPDATE 1-Gilead 4th-qtr profit misses Wall Street estimate, shares fall
February 04, 2019 at 17:42 PM EST
Gilead Sciences Inc on Monday reported a fourth-quarter profit that fell short of Wall Street estimates, sending shares lower, as sales of its flagship hepatitis C treatments continued to slide and the drugmaker recorded a large impairment charge related to its acquisition of Kite Pharma.